Use of avacopan in severe forms of ANCA-associated vasculitis. Comment on 'Inhibiting C5a/C5aR to treat ANCA-associated vasculitides' by Terrier et al. Joint Bone Spine 2023;90:105472

Autor:	Quentin Astouati, François Provot, Meryem-Maud Farhat, David Launay, Sébastien Sanges
Rok vydání:	2023
Předmět:	Rheumatology
Zdroj:	Joint Bone Spine. 90:105522
ISSN:	1297-319X
DOI:	10.1016/j.jbspin.2023.105522
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5627ec9c8c118fa5de6b0187b132b33a https://doi.org/10.1016/j.jbspin.2023.105522 Zobrazit plný text záznamu Full Text from ScienceDirect